Xelox PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
XELOX NO16967 Investigators Meeting PowerPoint PPT Presentation
XELOX NO16967 Investigators Meeting - XELOX NO16967 Investigators Meeting
XELOX NO16967 Investigators Meeting
| PowerPoint PPT presentation | free to view
XELOX NO16967 Investigators Meeting PowerPoint PPT Presentation
XELOX NO16967 Investigators Meeting - Rocky Mountain Cancer Centers, Denver, CO. US Oncology ... Paraesthesia 1. 8. 15. 18. Fatigue 1 1. 5. Hand-foot syndrome 1. 5. 5. 10. Vascular disorders ...
Rocky Mountain Cancer Centers, Denver, CO. US Oncology ... Paraesthesia 1. 8. 15. 18. Fatigue 1 1. 5. Hand-foot syndrome 1. 5. 5. 10. Vascular disorders ...
| PowerPoint PPT presentation | free to view
Xeloda combinations: adaptation in a constantly changing environment PowerPoint PPT Presentation
Xeloda combinations: adaptation in a constantly changing environment - Xeloda combinations: adaptation in. a constantly changing environment ... Xeloda can replace 5-FU/LV as the. backbone of combination therapy ...
Xeloda combinations: adaptation in. a constantly changing environment ... Xeloda can replace 5-FU/LV as the. backbone of combination therapy ...
| PowerPoint PPT presentation | free to view
Xeloda in colorectal cancer: moving into the adjuvant setting PowerPoint PPT Presentation
Xeloda in colorectal cancer: moving into the adjuvant setting - Cassidy J et al. Proc Am Soc Clin Oncol Late-breaking Abstract Book 2004;23:14 (Abst 3509) ... Cassidy J et al. Proc Am Soc Clin Oncol Late-breaking Abstract ...
Cassidy J et al. Proc Am Soc Clin Oncol Late-breaking Abstract Book 2004;23:14 (Abst 3509) ... Cassidy J et al. Proc Am Soc Clin Oncol Late-breaking Abstract ...
| PowerPoint PPT presentation | free to view
XELOX Shaping new outlooks in firstline treatment of colorectal cancer PowerPoint PPT Presentation
XELOX Shaping new outlooks in firstline treatment of colorectal cancer - Jim Cassidy. Cancer Research UK Department of Oncology. University of Glasgow. Glasgow, UK ... 2. Cassidy et al. Ann Oncol 2002. 3. Twelves et al. Eur J Cancer 2001 ...
Jim Cassidy. Cancer Research UK Department of Oncology. University of Glasgow. Glasgow, UK ... 2. Cassidy et al. Ann Oncol 2002. 3. Twelves et al. Eur J Cancer 2001 ...
| PowerPoint PPT presentation | free to view
Improving chemoradiotherapy regimens in rectal cancer PowerPoint PPT Presentation
Improving chemoradiotherapy regimens in rectal cancer - 1Dunst J et al. ECCO 12 2003 (Abst 282) ... Duck L et al. ECCO 12 2003 (Abst 260) Early safety results of XELOX-RT. Relative dose intensity ...
1Dunst J et al. ECCO 12 2003 (Abst 282) ... Duck L et al. ECCO 12 2003 (Abst 260) Early safety results of XELOX-RT. Relative dose intensity ...
| PowerPoint PPT presentation | free to view
Dirk Arnold PowerPoint PPT Presentation
Dirk Arnold - New treatment options for colorectal cancer with XELIRI Dirk Arnold Martin Luther University Halle Wittenberg, Germany Evolving role of irinotecan combinations in ...
New treatment options for colorectal cancer with XELIRI Dirk Arnold Martin Luther University Halle Wittenberg, Germany Evolving role of irinotecan combinations in ...
| PowerPoint PPT presentation | free to view
First efficacy and safety results from XELOX1NO16966, a randomised 2x2 factorial phase III trial of PowerPoint PPT Presentation
First efficacy and safety results from XELOX1NO16966, a randomised 2x2 factorial phase III trial of - Cancer Research UK Department of Oncology, University ... IV bolus. 5-FU 400mg/m2. IV bolus. Study objectives. Main endpoint = progression-free survival (PFS) ...
Cancer Research UK Department of Oncology, University ... IV bolus. 5-FU 400mg/m2. IV bolus. Study objectives. Main endpoint = progression-free survival (PFS) ...
| PowerPoint PPT presentation | free to view
ICH-E2A. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. 1994. PowerPoint PPT Presentation
ICH-E2A. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. 1994. - Title: PowerPoint Presentation Last modified by: ekru Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles
Title: PowerPoint Presentation Last modified by: ekru Created Date: 1/1/1601 12:00:00 AM Document presentation format: On-screen Show Other titles
| PowerPoint PPT presentation | free to view
Clinical trials of Avastin bevacizumab in colorectal cancer CRC PowerPoint PPT Presentation
Clinical trials of Avastin bevacizumab in colorectal cancer CRC - is the growth of new blood vessels from existing vessels and plays an a role in ... epistaxis was reported in one patient, proteinuria 1g/day in two patients and ...
is the growth of new blood vessels from existing vessels and plays an a role in ... epistaxis was reported in one patient, proteinuria 1g/day in two patients and ...
| PowerPoint PPT presentation | free to view
Clinical determinants of our choices PowerPoint PPT Presentation
Clinical determinants of our choices - Committee on Developing Biomarker-Based Tools for Cancer ... Kelloff GJ, Sigman CC. New science-based endpoints to accelerate oncology drug development. Eur J ...
Committee on Developing Biomarker-Based Tools for Cancer ... Kelloff GJ, Sigman CC. New science-based endpoints to accelerate oncology drug development. Eur J ...
| PowerPoint PPT presentation | free to view
Du m PowerPoint PPT Presentation
Du m - Title: Pr sentation PowerPoint Author: David Malka Created Date: 1/19/2006 5:06:28 PM Document presentation format: Affichage l' cran Other titles
Title: Pr sentation PowerPoint Author: David Malka Created Date: 1/19/2006 5:06:28 PM Document presentation format: Affichage l' cran Other titles
| PowerPoint PPT presentation | free to download
Place de la chimioth PowerPoint PPT Presentation
Place de la chimioth - Place de la chimioth rapie orale dans le traitement adjuvant du cancer colorectal Chimioth rapie adjuvante apr s r section de m tastases h patiques
Place de la chimioth rapie orale dans le traitement adjuvant du cancer colorectal Chimioth rapie adjuvante apr s r section de m tastases h patiques
| PowerPoint PPT presentation | free to download
KRAS Status in Response to Cetuximab PowerPoint PPT Presentation
KRAS Status in Response to Cetuximab - Title: PowerPoint Presentation Author: Efraim Idelevich Last modified by: Tsahi Created Date: 12/18/2004 7:38:29 AM Document presentation format: On-screen Show (4:3)
Title: PowerPoint Presentation Author: Efraim Idelevich Last modified by: Tsahi Created Date: 12/18/2004 7:38:29 AM Document presentation format: On-screen Show (4:3)
| PowerPoint PPT presentation | free to view
Standard Management of Stage IV Colorectal Cancer: Start and Stop, Maintenance, Chemotherapy Holidays PowerPoint PPT Presentation
Standard Management of Stage IV Colorectal Cancer: Start and Stop, Maintenance, Chemotherapy Holidays - Title: Standard Management of Stage IV Colorectal Cancer: Start and Stop, Maintenance, Chemotherapy Holidays Author: Partners Information Systems
Title: Standard Management of Stage IV Colorectal Cancer: Start and Stop, Maintenance, Chemotherapy Holidays Author: Partners Information Systems
| PowerPoint PPT presentation | free to download
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? PowerPoint PPT Presentation
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? - Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? Philippe Rougier
Do we need post-operative CHEMOTHERAPY in patients with PATHOLOGIC Complete Response to neoadjuvant therapy in RECTAL CANCER ? Philippe Rougier
| PowerPoint PPT presentation | free to download
Basi razionali della terapia perioperatoria PowerPoint PPT Presentation
Basi razionali della terapia perioperatoria - Basi razionali della terapia perioperatoria Antonio Frassoldati Ilaria Carandina Oncologia Clinica - Ferrara TransValid-KFO179/GRCSG-Trials Grade M et al, Langenbecks ...
Basi razionali della terapia perioperatoria Antonio Frassoldati Ilaria Carandina Oncologia Clinica - Ferrara TransValid-KFO179/GRCSG-Trials Grade M et al, Langenbecks ...
| PowerPoint PPT presentation | free to download
5year overall survival update from the XACT trial of capecitabine vs' 5FULV as adjuvant treatment fo PowerPoint PPT Presentation
5year overall survival update from the XACT trial of capecitabine vs' 5FULV as adjuvant treatment fo - 5-FU/LV as adjuvant treatment for stage III colon cancer ... First indication in the adjuvant setting from a cross-trial comparison showing ...
5-FU/LV as adjuvant treatment for stage III colon cancer ... First indication in the adjuvant setting from a cross-trial comparison showing ...
| PowerPoint PPT presentation | free to view
Metastatic Gastric Cancer PowerPoint PPT Presentation
Metastatic Gastric Cancer - Metastatic Gastric Cancer John L. Marshall, MD Lombardi Cancer Center Georgetown University Washington DC * * 1:1 * * * * Safety: non-hematological AEs AE, % F+C n ...
Metastatic Gastric Cancer John L. Marshall, MD Lombardi Cancer Center Georgetown University Washington DC * * 1:1 * * * * Safety: non-hematological AEs AE, % F+C n ...
| PowerPoint PPT presentation | free to view
Grupo Roche La opcin preferida por el onclogo PowerPoint PPT Presentation
Grupo Roche La opcin preferida por el onclogo - Grupo Roche. La opci n preferida por el onc logo. El l der en oncolog a con: Una extensa cartera de productos. Diversos productos innovadores en fase de I D ...
Grupo Roche. La opci n preferida por el onc logo. El l der en oncolog a con: Una extensa cartera de productos. Diversos productos innovadores en fase de I D ...
| PowerPoint PPT presentation | free to view
TRAITEMENT ADJUVANT et NEO-ADJUVANT DU CANCER COLO-RECTAL PowerPoint PPT Presentation
TRAITEMENT ADJUVANT et NEO-ADJUVANT DU CANCER COLO-RECTAL - Thierry Andr Servie d Oncologie M dicale Facult Paris VI, Pierre et Marie Curie H pital Saint Antoine et GERCOR DFS (3 ans) vs OS (5 ans) : Objectif principal ...
Thierry Andr Servie d Oncologie M dicale Facult Paris VI, Pierre et Marie Curie H pital Saint Antoine et GERCOR DFS (3 ans) vs OS (5 ans) : Objectif principal ...
| PowerPoint PPT presentation | free to view
Optimal Management of Liver Metastases: Present Results and Future Strategies PowerPoint PPT Presentation
Optimal Management of Liver Metastases: Present Results and Future Strategies - Preoperative CT. Resectable mts. Initially not-resectable mts. Hepatotoxicity of CT ... Pre-operative chemotherapy in resectable CRC liver metastases. 34/40 ...
Preoperative CT. Resectable mts. Initially not-resectable mts. Hepatotoxicity of CT ... Pre-operative chemotherapy in resectable CRC liver metastases. 34/40 ...
| PowerPoint PPT presentation | free to view
Upper GI Cancers: Risk Stratification and Treatment Selection PowerPoint PPT Presentation
Upper GI Cancers: Risk Stratification and Treatment Selection - Upper GI Cancers: Risk Stratification and Treatment Selection David H. Ilson, MD, PhD Gastrointestinal Oncology Service Memorial Sloan-Kettering Cancer Center
Upper GI Cancers: Risk Stratification and Treatment Selection David H. Ilson, MD, PhD Gastrointestinal Oncology Service Memorial Sloan-Kettering Cancer Center
| PowerPoint PPT presentation | free to download
Management of Colorectal Liver Metastasis Bert H. O PowerPoint PPT Presentation
Management of Colorectal Liver Metastasis Bert H. O - ... Stereotactic Body Radiation Therapy for Hepatic Metastases Local Control by SBRT Response to CyberKnife 90-Ytrrium Microspheres 90Y Microspheres for ...
... Stereotactic Body Radiation Therapy for Hepatic Metastases Local Control by SBRT Response to CyberKnife 90-Ytrrium Microspheres 90Y Microspheres for ...
| PowerPoint PPT presentation | free to view
Avastinв (bevacizumab) v lйcbe 1.linie metastazujнcнho karcinomu kolorekta PowerPoint PPT Presentation
Avastinв (bevacizumab) v lйcbe 1.linie metastazujнcнho karcinomu kolorekta - (bevacizumab) v l b 1.linie metastazuj c ho karcinomu kolorekta Srpen 2005 Obsah Novotvorba c v a VEGF VEGF a patologick angiogeneza v n doru Inhibice VEGF ...
(bevacizumab) v l b 1.linie metastazuj c ho karcinomu kolorekta Srpen 2005 Obsah Novotvorba c v a VEGF VEGF a patologick angiogeneza v n doru Inhibice VEGF ...
| PowerPoint PPT presentation | free to view
Whats on the Horizon? PowerPoint PPT Presentation
Whats on the Horizon? - Whats on the Horizon? David Thomson, Lead Pharmacist, Yorkshire Cancer Network.
Whats on the Horizon? David Thomson, Lead Pharmacist, Yorkshire Cancer Network.
| PowerPoint PPT presentation | free to download
David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine Institut Gustave Roussy Villejuif, France PowerPoint PPT Presentation
David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine Institut Gustave Roussy Villejuif, France - Treatment of Advanced HER2-Negative Gastroesophageal Carcinomas David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine
Treatment of Advanced HER2-Negative Gastroesophageal Carcinomas David Malka, MD, PhD Head of Gastrointestinal Tumor Group Department of Oncologic Medicine
| PowerPoint PPT presentation | free to download
Metastatic Colorectal Carcinoma PowerPoint PPT Presentation
Metastatic Colorectal Carcinoma - What are the options for palliative systemic therapy in someone deemed unfit for ... Options for palliative systemic therapy. Popa etal, JCO ASCO Proc, 23 supp, ...
What are the options for palliative systemic therapy in someone deemed unfit for ... Options for palliative systemic therapy. Popa etal, JCO ASCO Proc, 23 supp, ...
| PowerPoint PPT presentation | free to view
Topics in Oncology PowerPoint PPT Presentation
Topics in Oncology - Camptosar (irinotecan HCL injection) Prescribing Information. New York, NY: Pfizer, Inc. ... Promotes endothelial cell viability and proliferation. Chemotaxis ...
Camptosar (irinotecan HCL injection) Prescribing Information. New York, NY: Pfizer, Inc. ... Promotes endothelial cell viability and proliferation. Chemotaxis ...
| PowerPoint PPT presentation | free to view
Conservative treatment of liver metastasis PowerPoint PPT Presentation
Conservative treatment of liver metastasis - Steele Jr G et al., Ann Surg, 1989. COLORECTAL CANCER. LIVER METASTASES. Survival. benefit ... 3Goldberg R et al. Proc Am Soc Clin Oncol 2003;22:252 (Abst 1009) ...
Steele Jr G et al., Ann Surg, 1989. COLORECTAL CANCER. LIVER METASTASES. Survival. benefit ... 3Goldberg R et al. Proc Am Soc Clin Oncol 2003;22:252 (Abst 1009) ...
| PowerPoint PPT presentation | free to view
Adjuvant Chemotherapy PowerPoint PPT Presentation
Adjuvant Chemotherapy - ... capecitabine (X-ACT), FOLFOX (MOSAIC), and FLOX (NSABP CO ... Mosaic Trial. Adjuvant colon cancer. 2246 patients divided equally between arms. 40% Stage II ...
... capecitabine (X-ACT), FOLFOX (MOSAIC), and FLOX (NSABP CO ... Mosaic Trial. Adjuvant colon cancer. 2246 patients divided equally between arms. 40% Stage II ...
| PowerPoint PPT presentation | free to view
Ritmi circadiani e qualita PowerPoint PPT Presentation
Ritmi circadiani e qualita - ... TTP 8; OS 17 Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer.
... TTP 8; OS 17 Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer.
| PowerPoint PPT presentation | free to view
PowerPoint PPT Presentation
- Mauricio Lema Medina MD Cl nica de Oncolog a Astorga Cl nica SOMA Medic ncer Medell n, Colombia * * Goldberg RM, Sargent DJ, Morton RF, et al.
Mauricio Lema Medina MD Cl nica de Oncolog a Astorga Cl nica SOMA Medic ncer Medell n, Colombia * * Goldberg RM, Sargent DJ, Morton RF, et al.
| PowerPoint PPT presentation | free to download


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
xelox — Search results on PowerShow.com